Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Trauner, M; Boyer, JL.
Cholestatic syndromes.
Curr Opin Gastroenterol. 2004; 20(3):220-230
Doi: 10.1097/00001574-200405000-00006
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Purpose of review This review highlights recent developments in the molecular pathogenesis of cholestasis as well new aspects of pathogenesis and management of clinical cholestatic disorders.Recent findings Highlights include the role of nuclear receptors including FXR ligands as potential therapeutic agents, new genetic defects for pediatric cholestasis and sclerosing cholangitis, and novel infections and environmental agents as etiologies for primary biliary cirrhosis. Important clinical studies have been published in the area of pediatric cholestatic syndromes, intrahepatic cholestasis of pregnancy, primary biliary cirrhosis, primary and secondary sclerosing cholangitis, cholestasis of sepsis, viral cholestatic syndromes, and drug-induced cholestasis.Summary These advances continue to improve understanding of the pathophysiology, diagnosis, and management of cholestatic liver disease.
- Find related publications in this database (Keywords)
-
cholestasis
-
nuclear receptors
-
FXR
-
bile acid transporters
-
clinical cholestatic disorders